Top 25 oncology products in 2015

Despite the arrivals of new drugs, Genentech continues to be the market leader. Its drugs, Rituxan, Avastin, and Herceptin, are the category leaders, generating a total of $9.29 billion in sales.

July 25, 2016

12:00 pm

From the August 01, 2016 Issue of MM+M - Medical Marketing and Media

From Our Partners

Spectrum Science: Evolving marketing communications following COVID-19

Partner Content

Spectrum Science: Evolving marketing communications following COVID-19

The agency’s biopharma, biotech, health tech and consumer science experts weigh in on how the public’s heightened awareness of science affects stakeholders across the entire healthcare continuum.

The power of purpose

Partner Content

The power of purpose

How Biolumina’s focus on oncology connects the personal with scientific progress.

The emergence of Evolution Health Group

Partner Content

The emergence of Evolution Health Group

Larry Dobrow discusses the evolution of EHG over the past few years with Dr. Leo Francis, COO of EHG, and how his role will focus on creating transformative changes for both employees and clients.

MicroMass and the creative potential of Human Dynamics

Partner Content

MicroMass and the creative potential of Human Dynamics

A look beyond the disease and demographics to understand the human inside.